{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:17Z","timestamp":1786119077737,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/ftd.0b013e3181947916","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T03:38:43Z","timestamp":1232422723000},"page":"131-134","source":"Crossref","is-referenced-by-count":27,"title":["Evaluation of the Cozart DDSV Test for Cannabis in Oral Fluid"],"prefix":"10.1097","volume":"31","author":[{"given":"Pascal","family":"Kintz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Villain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cirimele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210129","first-page":"203","article-title":"Introduction and review of collection techniques and applications of drug testing of oral fluid.","volume":"30","author":"Drummer","year":"2008","journal-title":"Ther Drug Monit"},{"key":"R2-16-20210129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jat\/31.1.44","article-title":"Evaluation of ten oral fluid point-of-collection drug-testing devices.","volume":"31","author":"Walch","year":"2007","journal-title":"J Anal Toxicol"},{"key":"R3-16-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.forsciint.2006.03.033","article-title":"Correlation of delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Drager DrugTest.","volume":"161","author":"Laloup","year":"2006","journal-title":"Forensic Sci Int"},{"key":"R5-16-20210129","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/jat\/29.7.724","article-title":"Detection of cannabis use in drivers with the drugwipe device and by GC\/MS after Intercept device collection.","volume":"29","author":"Kintz","year":"2005","journal-title":"J Anal Toxicol"},{"key":"R6-16-20210129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.forsciint.2006.01.020","article-title":"Oral fluid testing for cannabis: on-site Oraline IV s.a.t. device versus GC\/MS.","volume":"161","author":"Cirimele","year":"2006","journal-title":"Forensic Sci Int"},{"key":"R7-16-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jat\/31.4.187","article-title":"Detection of conjugated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid.","volume":"31","author":"Moore","year":"2007","journal-title":"J Anal Toxicol"},{"key":"R8-16-20210129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.forsciint.2007.03.038","article-title":"Development and validation of the Cozart DDS oral fluid collection device.","volume":"170","author":"Speedy","year":"2007","journal-title":"Forensic Sci Int"},{"key":"R9-16-20210129","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/FTD.0b013e3181679249","article-title":"Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.","volume":"30","author":"Crouch","year":"2008","journal-title":"Ther Drug Monit"},{"key":"R10-16-20210129","first-page":"19673","article-title":"Proposed guidelines for mandatory drug testing.","volume":"69","year":"2004","journal-title":"Fed Regist"},{"key":"R11-16-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.forsciint.2004.11.022","article-title":"Review: pharmacokinetics of illicit drugs in oral fluid.","volume":"150","author":"Drummer","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R12-16-20210129","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jat\/31.5.288","article-title":"Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid.","volume":"31","author":"Kauert","year":"2007","journal-title":"J Anal Toxicol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e3181947916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:30:30Z","timestamp":1786037430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200902000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3181947916","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}